MedTrace Logo

Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia

NCT00429975 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2007-02-01

No results posted yet for this study

Summary

The purpose of this study is to compare levofloxacin vs ceftriaxone impact on the cytokine production in patients with pneumococcal pneumonia.

Conditions

  • Pneumonia, Pneumococcal

Interventions

DRUG

levofloxacin

DRUG

ceftriaxone

Sponsors & Collaborators

  • Fondo de Investigacion Sanitaria

    collaborator OTHER

  • Hospital Mutua de Terrassa

    lead OTHER

Principal Investigators

  • ESTHER CALBO, MD · Hospital Mutua de Terrassa

  • MONTSERRAT ALSINA, MD · HOSPITAL MUTUA TERRASSA

  • MARIONA XERCAVINS, MD · Hospital Mutua de Terrassa

  • EVA CUCHI, MD · Hospital Mutua de Terrassa

  • MONICA RODRIGUEZ-CARBALLEIRA, PhD · Hospital Mutua de Terrassa

  • JAVIER GARAU, PhD · Hospital Mutua de Terrassa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Completion
2005-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00429975 on ClinicalTrials.gov